Matches in Nanopublications for { ?s ?p "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP42169.RAslhBF72Yuo0tUWYZ0_BXVfjBl7B9H6-GIxXYzOgoC9A130_assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42169.RAslhBF72Yuo0tUWYZ0_BXVfjBl7B9H6-GIxXYzOgoC9A130_provenance.
- NP36496.RAfEHOtLiWdLkEmyggnY8fsX3yfQ7KCkdQEOcWarkSaMo130_assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP36496.RAfEHOtLiWdLkEmyggnY8fsX3yfQ7KCkdQEOcWarkSaMo130_provenance.
- assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP49210.RAfSCtf3ht0Iuf9aX6e6mIMeKr70n2hC-7de0Rb2TUTqA130_assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP49210.RAfSCtf3ht0Iuf9aX6e6mIMeKr70n2hC-7de0Rb2TUTqA130_provenance.
- assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP42403.RAgFFfpr19aDajEUjfFqBigzCq1rZ8BMJWJzDrc5bvnBA130_assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP42403.RAgFFfpr19aDajEUjfFqBigzCq1rZ8BMJWJzDrc5bvnBA130_provenance.
- NP64330.RASpkqpUff7TXWsdMlXHyQGt2DNQhlHBp36AQRksciJTA130_assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64330.RASpkqpUff7TXWsdMlXHyQGt2DNQhlHBp36AQRksciJTA130_provenance.
- NP64331.RAyxqS3wiLDNRhCmOspri3jbxLMEz1dBie98PnRoTL-mE130_assertion description "[Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64331.RAyxqS3wiLDNRhCmOspri3jbxLMEz1dBie98PnRoTL-mE130_provenance.